Charlotte Hauser

Title: Charlotte Hauser: Innovator in Recombinant Glycoproteins

Introduction

Charlotte Hauser is a prominent inventor based in München, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant glycoproteins. Her work has implications for various medical applications, especially in the human circulatory system.

Latest Patents

Charlotte Hauser holds a patent for "Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof." This invention relates to novel recombinant glycoproteins that serve as messenger substances, signaling substances, promoters, stimulators, and initiators in the animal, particularly human, circulatory system. The patent details a method for producing these glycoproteins and outlines their use in pharmaceutical agents. Specifically, her work includes recombinant human glycoproteins such as erythropoietin, colony stimulating factors, granulocytes monocytes stimulation factors, thrombolytic agents, thromboprophylactic agents, coagulation factors, interferons, and interleukins.

Career Highlights

Throughout her career, Charlotte has focused on advancing the understanding and application of glycoproteins in medicine. Her innovative approach has led to the development of critical therapeutic agents that can significantly impact patient care and treatment outcomes.

Collaborations

Charlotte has collaborated with notable professionals in her field, including Werner Reutter and Rudolf Tauber. These partnerships have enhanced her research and contributed to the successful development of her patented technologies.

Conclusion

Charlotte Hauser is a trailblazer in the field of recombinant glycoproteins, with a patent that showcases her innovative contributions to biotechnology. Her work continues to influence medical science and offers promising avenues for future research and development.